RNO.AX
Price:
$0.04
Market Cap:
$11.47M
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and ...[Read more]
Industry
Medical - Devices
IPO Date
2007-09-21
Stock Exchange
ASX
Ticker
RNO.AX
According to Rhinomed Limited’s latest financial reports and current stock price. The company's current ROE is 195.26%. This represents a change of -136.10% compared to the average of -540.94% of the last 4 quarters.
The mean historical ROE of Rhinomed Limited over the last ten years is -70.60%. The current 195.26% ROE has changed -376.56% with respect to the historical average. Over the past ten years (40 quarters), RNO.AX's ROE was at its highest in in the June 2023 quarter at 97.63%. The ROE was at its lowest in in the December 2022 quarter at -2221.03%.
Average
-70.60%
Median
-84.15%
Minimum
-181.34%
Maximum
170.29%
Discovering the peaks and valleys of Rhinomed Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.98%
Maximum Annual ROE = 170.29%
Minimum Annual Increase = -262.34%
Minimum Annual ROE = -181.34%
Year | ROE | Change |
---|---|---|
2023 | 170.29% | -262.34% |
2022 | -104.89% | -42.16% |
2021 | -181.34% | 170.98% |
2020 | -66.92% | -47.95% |
2019 | -128.57% | 53.05% |
2018 | -84.00% | 0.84% |
2017 | -83.30% | -1.19% |
2016 | -84.30% | -5.38% |
2015 | -89.10% | 65.41% |
2014 | -53.87% | -84.37% |
The current ROE of Rhinomed Limited (RNO.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-38.65%
5-year avg
-62.29%
10-year avg
-70.60%
Rhinomed Limited’s ROE is greater than IDT Australia Limited (-23.28%), greater than Botanix Pharmaceuticals Limited (-18.00%), greater than Incannex Healthcare Limited (-77.78%), less than Zelira Therapeutics Limited (1.07%), greater than Stemcell United Limited (-66.48%),
Company | ROE | Market cap |
---|---|---|
-23.28% | $46.49M | |
-18.00% | $863.37M | |
-77.78% | $65.07M | |
1.07% | $7.15M | |
-66.48% | $3.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhinomed Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rhinomed Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Rhinomed Limited's ROE?
How is the ROE calculated for Rhinomed Limited (RNO.AX)?
What is the highest ROE for Rhinomed Limited (RNO.AX)?
What is the 3-year average ROE for Rhinomed Limited (RNO.AX)?
What is the 5-year average ROE for Rhinomed Limited (RNO.AX)?
How does the current ROE for Rhinomed Limited (RNO.AX) compare to its historical average?